Table 2.
Differentiability of the regions based on the relative enhancement (RE) after application of gadobutrol (upper right section) and the elastin-specific probe (lower left section) together for all examination time points.
| Gadobutrol | |||||
|---|---|---|---|---|---|
| Central | Margin | Peritumoral | Liver | Muscle | |
| Central | 1.52*** | − .59* | − .08 | .13 | .35 |
| Margin | − 1.24*** | 2.43*** | .51 | .71** | .93** |
| Peritumoral | − .04 | 1.20*** | 1.58*** | .20 | .42 |
| Liver | 1.12*** | 2.36*** | 1.16*** | .90*** | .22 |
| Muscle | 1.26*** | 2.50*** | 1.30*** | − .14 | .72** |
| Elastin-specific probe | |||||
Diagonal (bold print): strength of region discrimination (Bonferroni-corrected) using the elastin-specific probe compared to gadobutrol. Upper section: crude differences in gadobutrol RE between regions (central, margin, peritumoral, liver, muscle). Lower section: crude differences in elastin-specific RE between regions (central, margin, peritumoral, liver, muscle).
*P < .05; **P < .01; ***P < .001.